{"url_path":"/sec/jsprw/8-k/2026-05-21/item-5-02","section_key":"item-5-02","section_title":"Item 5.02 Departure of Directors or Certain Officers; Election of Directors;","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-05-21","source_url":"https://www.sec.gov/Archives/edgar/data/1788028/0001213900-26-060029-index.html","accession_number":"0001213900-26-060029","cik":"0001788028","ticker":"JSPR","issuer_name":"Jasper Therapeutics, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1788028/0001213900-26-060029-index.html","primary_entity_key":"0001788028","primary_entity_name":"Jasper Therapeutics, Inc."},"word_count":106,"has_tables":true,"body_markdown":"** **\n\n \n\n \n\n \n\n** **\n\n**Item 5.02. Departure of Directors or Certain Officers; Election of Directors;\nAppointment of Certain Officers; Compensatory Arrangements of Certain Officers.**\n\n** **\n\nOn May 15, 2026 (the “Notice Date”), Christian Nolet informed\nthe Board of Directors (the “Board”) of Jasper Therapeutics, Inc. (the “Company”) that he is resigning from the\nBoard and the committees of the Board on which he serves, effective as of the Notice Date. Mr. Nolet’s resignation is not a result\nof any disagreement with the Company on any matter relating to the Company’s operations, policies or practices.\n\n \n\nThe Board has appointed Svetlana Lucas, Ph.D. as a member of the Audit\nCommittee of the Board."}